Eight cases of congenital sucrase-isomaltase deficiency were studied at the subcellular and protein level with monoclonal antibodies against sucrase-isomaltase. At least three phenotypes were revealed: one in which sucrase-isomaltase protein accumulated intracellularly probably in the endoplasmic reticulum, as a membrane-associated high-mannose precursor, one in which the intracellular transport of the enzyme was apparently blocked in the Golgi apparatus, and one in which catalytically altered enzyme was transported to the cell surface. All patients expressed electrophoretically normal or near normal high-mannose sucrase-isomaltase. The results suggest that different, probably small, mutations in the sucrase-isomaltase gene lead to the synthesis of transport-incompetent or functionally altered enzyme which results in congenital sucrose intolerance.
Introduction
Recent progress in understanding the mechanisms underlying the biogenesis and intracellular transport of membrane and secretory proteins has lead to the notion of compartmentalization of the eukaryotic cell into structurally and functionally distinct biosynthetic organelles (1, 2) . Newly synthesized plasma membrane proteins migrate from the endoplasmic reticulum to the cell surface via the Golgi apparatus (3, 4) . On their way to the cell surface most proteins undergo some type of covalent modification including glycosylation, fatty acid acylation, phosphorylation, or proteolytic cleavage (5) (6) (7) . However, the molecular basis of selective protein transport from organelle to organelle is poorly understood (8, 9) .
A promising approach for investigating membrane traffic is the analysis of naturally occurring phenotypes with impaired protein targeting (10, 11) . Congenital sucrase-isomaltase deficiency (CSID),' an autosomal recessive disease of the human the peroral biopsy samples used in the present study were histologically normal. The biopsy specimens (5-30 mg wet weight) were taken with a pediatric-sized Watson capsule (Watson Products, Inc., Pasadena, CA) and were cut into several fragments approximately equal in size. One piece was immediately fixed for immunoelectron microscopy, two pieces were frozen at -70'C for enzyme measurements and '25I-labeling experiments, respectively, and two to three pieces were placed in organ culture for the metabolic labeling of SI. The frozen tissue samples were analyzed within 1-3 mo.
Antibodies. All the monoclonal antibodies used have been described (20) . They include HB1B2/6 14 1 Ag/ml pepstatin, 5 gtg/ml leupeptin, 17.4 tg/ml benzamidine, and 1 gg/ml aprotinin. The homogenates were subjected to immunoprecipitation as described below. '251-labeling. The lactoperoxidase-glucose-oxidase method was used for radioiodcination of Triton X-100-solubilized mucosal tissue as described (20) . 1 mCi carrier-free Na'25I was used for each iodination.
Immunoprecipitation and digestion with endoglycosidase H and SDS-PAGE. 2 ml of homogenate of each [35S] methionine-labeled tissue fragment waE solubilized with Nonidet P-40 and sodium deoxycholate, 0.5% (wt/vol) final concentration each, by stirring on ice for 30 min. The solubilized material was centrifuged at 100,000 g for 1 h at 4°C. The resulting supernatant was divided into two identical aliquots, and each aliquot was incubated for 2 h at 4°C with protein A-Sepharose beads to which the four monoclonal antibodies against SI had been adsorbed (20) . Other brush border enzymes (i.e., aminopeptidase N, dipeptidylpeptidase IV, lactase, maltase-glucoamylase, and angiotensin-converting enzyme) were immunoisolated for control purposes by subjecting the SI-depleted detergent extract to sequential immunoprecipitation with monoclonal antibodies that were covalently coupled to cyanogen bromide (CNBr)-activated Sepharose. Usually 35 Laemmli (32) . The molecular mass standards were myosin (202 kD), j3-galactosidase (1 16 
Results
The CSID of the patients was initially detected by the sucrose challenge test and has been confirmed in the present study by the measurement ofbrush border enzyme activities in mucosal homogenates (Table I) . Sucrase activities were either below the detection limit (cases 1 and 2) or at least 10-fold lower than the average values of control biopsies. Very low residual' isomaltase activity was measurable in six cases whereas in the remaining two cases (7 and 8) the isomaltase activity was close to normal. The low residual isomaltase activity was not due to unrelated saccharidases since it was quantitatively immunoprecipitable with monoclonal antibodies against SI (not shown). Maltase activity was either normal (cases 4, 7, and 8) or was at least twofold reduced (remaining cases). This result is explainable by the known fact that SI contributes 70-90% to the overall brush border maltase activity while the remaining activity is due to a separate enzyme, maltase-glucoamylase, which most likely is not affected by CSID (see Fig. 3 A, but see also Skovbjerg [36] ). Lactase activity was normal with the exception of case 1 in which it was somewhat decreased and case 4 in which it was slightly elevated ( Table I ). The activities of other brush border enzymes including aminopeptidase N and alkaline phosphat~ase were in the normal range (not shown).
These biochemical data demonstrate in all cases an isolated enzyme defect associated with SI. Furthermore, the findings of residual isomaltase activity in all the patients pointed to the possibility that CSID was not a consequence of a complete to isolated CSID or due to a more general defect in glycosylation or a disturbance of protein transport the biogenesis of aminopeptidase N was studied. In both the patient and the control aminopeptidase N was synthesized as an endo H-sensitive, 1 30-kt), high-mannose precursor which was efficiently converted to the endo H-resistant, 160-kD, fully glycosylated form within 4 h (Fig. 1) . We conclude therefore that the disturbance of glycoprotein maturation in the patient is restricted to SI and does not reflect a general defect in glycosylation. To obtain information on a possible gross structural alteration of the residual SI, immunoprecipitation experiments with monoclonal antibodies HBB 2/614, HI3B 2/219, HBB 1/691, and HBB 3/705 against four different epitopes of SI were carried out (20) . After 125I labeling, the 2 10-kD protein was immunoprecipitable with each of the antibodies, suggesting that the four epitopes were not changed (not shown). Reactivity with antibody HBB 3/705, which recognizes an early form of pro-SIh (20) was weak in comparison to the other antibodies but was comparable to normal controls.
Overall, the data confirm and extend the conclusions drawn in our previous study (13) that CSID in this patient is due to the synthesis of electrophoretically normal pro-SIh which, however, fails to undergo complex-type glycosylation as an intact molecule. The finding that pro-SIh ofthe patient is electrophoretically indistinguishable from normal pro-SIh suggests normal trimming of its high-mannose glycans. We believe therefore that the abnormal pro-SIh is degraded either in the endoplasmic reticulum before exit to the Golgi or in the cis-Golgi apparatus.
Case 2. This case is enzymatically (Table I) and immunocytochemically similar to case 1. It is characterized by the lack of immunoreactive SI in the brush border and a significant immunolabel in the medial-and trans-Golgi cisternae including the trans-Golgi network and smooth vesicular profiles (Fig.  2, a-c) . Immunolabel was absent over the endoplasmic reticulum and lysosomes. Electrophoretically normal pro-SIh was immunoprecipitable from '25I-labeled mucosal protein with a mixture of the four monoclonal antibodies while no pro-SLI nor SI subunits were detectable (Fig. 3 A) . When used individually, antibodies HBB 1/691 and HBB 2/219 failed to immunoprecipitate the pro-SIh ofthe patient suggesting that the corresponding two epitopes were altered (Fig. 3 B, lanes 8 and JO) . The (Fig. 4, lanes 11 and 12) . Interestingly, part ofthe 212-kD protein ofpatient 3 was also endo H resistant after 4 h. This latter finding is unlikely to be due to incomplete action of endo H since other SI immunoprecipitates as well as immunoprecipitates obtained with aminopeptidase N run in parallel showed complete digestion (Fig. 4) . Complex-glycosylated aminopeptidase N also showed a higher mean electrophoretic M, in case 4 than in case 3 suggesting differences in the complex-type glycans. This may reflect differences in blood groups of the two patients. Human brush border enzymes are indeed known to carry blood group antigens (38, 39) . Immunoprecipitation experiments with detergent-solubilized I'2l-labeled proteins were carried out for case 3. Fig. 5 (20) . This indicates that in the patient pro-SIh fails to undergo an early maturation event. There was a striking apparent overexpression of pro-SIb in the patient when compared to the normal control (Fig. 5, lanes 1 and 2) but no cleaved subunits were detectable, suggesting that the enzyme was not transported to the brush border. To evaluate if pro-SIh of the patient was still membrane associated, an aliquot of the homogenate was freeze-thawed, sonicated, and subjected to ultracentrifugation (100,000 g for 1 h). The resulting particular and soluble fractions were separately radioiodinated and immunoprecipitated. Fig. 5 B shows that pro-SIh was quantitatively precipitated from the particulate fraction and hence was probably still membrane bound. Immunoelectron microscopy was not performed with,these two cases.
Case 5. This patient combines features of cases 1 and 4.
Similarly to case 1, its SI was synthesized as an electrophoretically normal, endo-H-sensitive, 2 10-kD protein (Fig. 6 , lanes I and 2) at close to normal levels. There was a weak immunolabeling of the Golgi apparatus but complete absence of immunoreactive SI from the brush border as revealed by immunoelectron microscopy (not shown). Unlike case 1 but similarly to case 4, a small fraction of the pro-SIh underwent complex glycosylation (Fig. 6, lanes 3 and 4) . No cleaved subunits were immunoprecipitable from the 1251I-labeled homogenate (not shown). Biosynthesis and processing of aminopeptidase N proceeded normally. Newly synthesized pro-SIh was immunoprecipitable with all four anti-SI antibodies whereas pro-SI, as expected, was not recognized by HBB3/705 (Fig. 6 B) . The strong reactivity of pro-SIh with antibody 3/705 suggests that maturation of the proform is not taking place or is slowed down. Overall, these results suggest synthesis but inefficient maturation of pro-SIh along the endoplasmic reticulum to the trans-Golgi pathway. The enzyme is probably degraded intracellularly as indicated by the presence of several immunoreactive proteins of lower Mr (Fig. 6, lane 3) . Case 6. This patient is similar but not identical to case 1. Its mucosa was able to synthesize pro-SIh which failed to undergo complex glycosylation even after 16 h (Fig. 7 A) . The total amount of 1251I-labeled pro-SIh was significantly lower than that of the control specimen (Fig. 7 B, lanes 2 and 3) while the amount of immunoprecipitable lactase was comparable (lanes 5 and 6). Newly synthesized pro-SIh was immunoprecipitable with all four antibodies to SI (Fig. 7 C) . Most notably strong reactivity was observed with antibody HBB 3/705 (lane 2). As in the previous cases the biosynthesis ofaminopeptidase N was (Fig. 7 A) . At 16 h the radioactivity in pro-SIh was significantly lower than at 4 h. Aminopeptidase N showed the opposite trend. Since in normal biopsies the incorporation of [35S]methionine into both SI and aminopeptidase N regularly increased between 4 and 16 h (not shown), the results of the patient most likely reflect an increased intracellular turnover of the residual SI. Weak immunolabeling was detectable by immunoelectron microscopy over the Golgi apparatus and surrounding smooth vesicular and tubular profiles while the brush border showed no labeling (Fig. 2, d and e) . The data suggest that in this patient somewhat lower than normal levels of pro-SIh were synthesized or persisted and that SI failed to undergo maturation and transport to the cell surface.
tional immunolabel is found in the smooth endoplasmic reticulum (arrowheads in d). The brush border is not labeled (e). N, part of the nucleus. Magnifications: (a) 29,000; (b) 37,000; (c) 27,500; (d) 34 ,000; (e) 27,500.
Cases 7 and 8. These patients are identical male twins. Already their high residual isomaltase activity in mucosal homogenates (Table I ) indicated a phenotype different from the previous cases. In fact, the organ culture experiment showed normal biosynthesis and processing of SI (Fig. 8 A) . By electron microscopy the brush border exhibited immunolabel of variable intensity (Fig. 9 ). In addition, weak immunolabel occurred along the basolateral plasma membrane, over the Golgi apparatus and the smooth endoplasmic reticulum in apical cell regions. In accord with the brush border labeling is the presence ofcleaved enzyme subunits on gels run with immunoprecipitates of 251I-labeled SI of the patient (Fig. 8 C) . As ii " -.. freeze-thawed, sonicated, and subjected to centrifugation (100,000 g for 1 h face but increased intensity of label in the medial and trans cisternae of the Golgi apparatus. The weak reaction of 1251I-labeled pro-SIh with the conformation-specific antibody HBB3/705, which was indistinguishable from that of the normal control, indicates that the residual enzyme in phenotype II has undergone a more complete maturation than in phenotype I. We believe that in these cases SI is normally transported to the Golgi apparatus but is degraded prior to complex glycosylation possibly in the cis-Golgi apparatus. A recently described case of CSID by Lloyd and Olsen (28) showed some similar features and may therefore belong to the same phenotype. Our cases 5 and 6 exhibit a similar phenotype. However, the presence of some complex-type pro-SI in case 5 and the strong reactivity of antibody HBB3/705 with the residual SI in case 6 argue in favour of different mutations.
In phenotype III, represented by the identical twins (cases 7 and 8), SI is transported to the brush border and cleaved into subunits. In these patients the mutation affects the catalytic activity of the sucrase subunit only, with little consequences for intracellular transport. However, the highly variable immunolabeling of the brush border and the presence of immunolabel over the basolateral membrane which was never observed with control specimens suggests a partial missorting of SI.
The present data lend conclusive support to the hypothesis ofDubs et al. (27) , who proposed that different mutations may lead to CSID. These authors reported presence of cross-reacting material in enzyme-deficient intestine by use of indirect immunofluorescence. These data apparently conflicted with those ofGray et al. (44) , who demonstrated absence ofenzyme variant in 7 patients with CSID by radioimmunoassay. Surprisingly, Gray et al. (44) found a higher than normal fraction of enzymatically inactive SI with heterozygote carriers. This finding was suggested to reflect a conversion of active to inactive enzyme in the heterozygotes owing to substrate deprivation. Our results offer another explanation of the data of these authors. It seems likely that the CSID patients described in that study had in fact phenotype II, i.e., presence of pro-SIh. This intracellular form may have escaped detection by radioimmunoassay due to the small amount present or was degraded during the incubation of the homogenate with papain. In heterozygote carriers on the other hand, the enzyme variant may have been stabilized and even transported to the cell surface by participating in the formation of dimers (45) with the wildtype enzyme from the normal allele as has been found in other autosomal recessive diseases (46 port of SI at the endoplasmic reticulum or the Golgi apparatus. Failure of SI to efficiently leave the endoplasmic reticulum appears to be correlated with a lack of a conformational change detected by monoclonal antibody HBB3/705, which shows maximal reactivity with normal pro-SIh after a 1 5-min chase but fails to recognize later forms of pro-SIh (20) . The epitope of this antibody has been narrowed by cDNA cloning to 100 amino acids on the isomaltase domain of SI and was found not to comprise N-glycosylation sites (53) . One might speculate that the exit of SI from the endoplasmic reticulum requires a conformational change reflecting proper folding (54-56) which involves at least one epitope on the isomaltase domain. In line with this idea is the observation that pro-SIh of cases 1 and 2 which showed accumulation of cross-reacting material in the Golgi apparatus had indeed undergone this conformational change. Such a change might be necessary for binding to a transport receptor (57). Lack of transport beyond the Golgi apparatus must be due to changes in other parts of SI as indicated by case 2 in which pro-SIb cannot be immunoprecipitated with antibodies HBB 2/219 and HBB 1/691. However, disruption of transport at the Golgi apparatus does not correlate with an alteration of the corresponding two epitopes in case 1.
Transport-incompetent variants designated class 2 mutations have also been found for the low density lipoprotein receptor (58) . Three of these mutations were analyzed at the molecular level and the data suggested that all three of the mutations can be expected to distort the receptor in such a way that some of the cysteines can no longer form disulfide bonds. The authors proposed that unpaired cysteine residues may be available for complexing to another protein that retards movement to the cell surface or that the improperly folded protein might bind noncovalently to a hypothetical gatekeeper protein in the endoplasmic reticulum whose function is to prevent export of improperly folded proteins (59) . Analysis of CSID at the gene level can be expected to provide interesting clues to the question of why these mutations disrupt the transport of SI to the cell surface.
